Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank M Longo

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Nature Medicine|May 17, 2024
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trialHayley R C Shanks, Kewei Chen, Eric M Reiman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2011
Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitorsDaniel Fisher, Bin Xing, John Dill, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 31, 2021
Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75<sup>NTR</sup> Ligand LM11A-31Danielle A Simmons, Brian D Mills, Robert R Butler Iii, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic miceThuy-Vi V Nguyen, Lin Shen, Lilith Vander Griend, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2025
Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington's disease phenotypesDanielle A Simmons, Sridhar Selvaraj, Tingshuo Chen, et al.
Biorxiv : the Preprint Server for Biology|October 2, 2023
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse modelAmira Latif-Hernandez, Tao Yang, Robert Raymond-Butler, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Uncovering Heterogeneous Effects via Localized Feature SelectionXiaoxia Liu, Jiaqi Gu, Zhaomeng Chen, et al.
Neurobiology of Disease|January 15, 2018
Glial scars are permeable to the neurotoxic environment of chronic stroke infarctsJacob C Zbesko, Thuy-Vi V Nguyen, Tao Yang, et al.
Plos One|November 4, 2008
Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairmentTao Yang, Juliet K Knowles, Qun Lu, et al.
Theranostics|May 23, 2017
[<sup>18</sup>F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's DiseaseMichelle L James, Nadia P Belichenko, Adam J Shuhendler, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Nature Medicine|May 17, 2024
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trialHayley R C Shanks, Kewei Chen, Eric M Reiman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2011
Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitorsDaniel Fisher, Bin Xing, John Dill, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 31, 2021
Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75<sup>NTR</sup> Ligand LM11A-31Danielle A Simmons, Brian D Mills, Robert R Butler Iii, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic miceThuy-Vi V Nguyen, Lin Shen, Lilith Vander Griend, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2025
Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington's disease phenotypesDanielle A Simmons, Sridhar Selvaraj, Tingshuo Chen, et al.
Biorxiv : the Preprint Server for Biology|October 2, 2023
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse modelAmira Latif-Hernandez, Tao Yang, Robert Raymond-Butler, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Uncovering Heterogeneous Effects via Localized Feature SelectionXiaoxia Liu, Jiaqi Gu, Zhaomeng Chen, et al.
Neurobiology of Disease|January 15, 2018
Glial scars are permeable to the neurotoxic environment of chronic stroke infarctsJacob C Zbesko, Thuy-Vi V Nguyen, Tao Yang, et al.
Plos One|November 4, 2008
Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairmentTao Yang, Juliet K Knowles, Qun Lu, et al.
Theranostics|May 23, 2017
[<sup>18</sup>F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's DiseaseMichelle L James, Nadia P Belichenko, Adam J Shuhendler, et al.
Pageof 11